170 related articles for article (PubMed ID: 23715647)
21. MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1.
Wang HL; Zhou R; Liu J; Chang Y; Liu S; Wang XB; Huang MF; Zhao Q
Sci Rep; 2017 Sep; 7(1):11467. PubMed ID: 28904340
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD44 in pancreatic cancer and its significance.
Li XP; Zhang XW; Zheng LZ; Guo WJ
Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
[TBL] [Abstract][Full Text] [Related]
23. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
25. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
Li BS; Liu H; Yang WL
Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas.
Mei M; Deng D; Liu TH; Sang XT; Lu X; Xiang HD; Zhou J; Wu H; Yang Y; Chen J; Lu CM; Chen YJ
J Clin Endocrinol Metab; 2009 Sep; 94(9):3448-57. PubMed ID: 19567531
[TBL] [Abstract][Full Text] [Related]
27. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells.
Chen WY; Liu WJ; Zhao YP; Zhou L; Zhang TP; Chen G; Shu H
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):319-24. PubMed ID: 22672828
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
Zhang ZB; Liu N
Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
[TBL] [Abstract][Full Text] [Related]
29. Role of miR
Liu Y; Hu Q; Ao J; Li H; Li M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):280-289. PubMed ID: 32386020
[TBL] [Abstract][Full Text] [Related]
30. Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1.
Huang C; Li H; Wu W; Jiang T; Qiu Z
Oncol Rep; 2013 Sep; 30(3):1223-30. PubMed ID: 23817566
[TBL] [Abstract][Full Text] [Related]
31. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
Ma YB; Li GX; Hu JX; Liu X; Shi BM
Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
33. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis.
Ning Z; Wang A; Liang J; Liu J; Zhou T; Yan Q; Wang Z
Int J Clin Exp Pathol; 2014; 7(5):2462-9. PubMed ID: 24966957
[TBL] [Abstract][Full Text] [Related]
35. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
[TBL] [Abstract][Full Text] [Related]
36. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
38. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer.
Shang S; Wang J; Chen S; Tian R; Zeng H; Wang L; Xia M; Zhu H; Zuo C
Cancer Med; 2019 Dec; 8(18):7728-7740. PubMed ID: 31642612
[TBL] [Abstract][Full Text] [Related]
39. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
[TBL] [Abstract][Full Text] [Related]
40. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.
Zhao G; Zhang JG; Shi Y; Qin Q; Liu Y; Wang B; Tian K; Deng SC; Li X; Zhu S; Gong Q; Niu Y; Wang CY
PLoS One; 2013; 8(9):e73803. PubMed ID: 24040078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
